{"url_path":"/sec/alzn/10-k/2026/item-5","section_key":"item-5","section_title":"Item 5 ****MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","accession_number":"0001214659-26-008832","cik":"0001677077","ticker":"ALZN","issuer_name":"Alzamend Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","primary_entity_key":"0001677077","primary_entity_name":"Alzamend Neuro, Inc."},"word_count":286,"has_tables":true,"body_markdown":"** **\n\n**ITEM 5.****MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY\nSECURITIES**\n\n \n\n**Market Information**\n\n \n\nOur common stock is listed\non The NASDAQ Capital Market under the symbol “ALZN.” Effective May 12, 2025, we effected a one-for-nine reverse split of\nour common stock.\n\n \n\n**Holders of Record**\n\n \n\nAs of July 22, 2026, there\nwere approximately 58 stockholders of record of our common stock. The actual number of stockholders is greater than this number of record\nholders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This\nnumber of holders of record also does not include stockholders whose shares may be held in trust or by other entities.\n\n \n\n**Dividend Policy**\n\n \n\nWe have never declared or\npaid any cash dividends on our capital stock, and we do not currently intend to pay any cash dividends on our capital stock in the foreseeable\nfuture. We currently intend to retain all available funds and any future earnings to support operations and to finance the growth and\ndevelopment of our business. Any future determination to pay dividends will be made at the discretion of our Board subject to applicable\nlaws and will depend upon, among other factors, our results of operations, financial condition, contractual restrictions and capital requirements.\nOur future ability to pay cash dividends on our capital stock may be limited by any future debt instruments or preferred securities.\n\n \n\n**Equity Compensation Information**\n\n \n\nThe information required by\nthis item regarding equity compensation plans is incorporated by reference to the information set forth in Item 12 of this Annual\nReport on Form 10-K.\n\n \n\n**Recent Sales of Unregistered Securities**\n\n \n\nNone.\n\n \n\n**Purchases of Equity Securities by the Issuer\nand Affiliated Purchasers**\n\n** **\n\nNone."}